|
1
|
Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.
|
Cancer J
|
2012
|
1.35
|
|
2
|
Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.
|
Curr Opin Mol Ther
|
2009
|
1.35
|
|
3
|
The art of gene therapy for glioma: a review of the challenging road to the bedside.
|
J Neurol Neurosurg Psychiatry
|
2012
|
1.24
|
|
4
|
Experimental approaches for the treatment of malignant gliomas.
|
Pharmacol Ther
|
2010
|
1.23
|
|
5
|
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.
|
Cancer Res
|
2014
|
1.20
|
|
6
|
Gene therapy and targeted toxins for glioma.
|
Curr Gene Ther
|
2011
|
0.97
|
|
7
|
Glioma virus therapies between bench and bedside.
|
Neuro Oncol
|
2014
|
0.95
|
|
8
|
Oncolytic measles virus strains as novel anticancer agents.
|
Expert Opin Biol Ther
|
2013
|
0.95
|
|
9
|
Sui generis: gene therapy and delivery systems for the treatment of glioblastoma.
|
Neuro Oncol
|
2015
|
0.94
|
|
10
|
What next for newly diagnosed glioblastoma?
|
Future Oncol
|
2015
|
0.94
|
|
11
|
Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma.
|
Neuro Oncol
|
2012
|
0.91
|
|
12
|
Current status of gene therapy for brain tumors.
|
Transl Res
|
2012
|
0.90
|
|
13
|
Antigen-specific vaccines for cancer treatment.
|
Hum Vaccin Immunother
|
2014
|
0.89
|
|
14
|
Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
|
Discov Med
|
2010
|
0.88
|
|
15
|
Strategies in gene therapy for glioblastoma.
|
Cancers (Basel)
|
2013
|
0.87
|
|
16
|
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses.
|
Mol Ther Methods Clin Dev
|
2016
|
0.86
|
|
17
|
EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA.
|
Drugs Future
|
2016
|
0.84
|
|
18
|
Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data.
|
Hum Gene Ther
|
2015
|
0.83
|
|
19
|
Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics.
|
Virology
|
2015
|
0.83
|
|
20
|
Gene therapy for malignant glioma.
|
Mol Cell Ther
|
2014
|
0.83
|
|
21
|
Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1.
|
Front Oncol
|
2014
|
0.82
|
|
22
|
Measles virus entry through the signaling lymphocyte activation molecule governs efficacy of mantle cell lymphoma radiovirotherapy.
|
Mol Ther
|
2013
|
0.82
|
|
23
|
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine.
|
BMC Cancer
|
2012
|
0.82
|
|
24
|
Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors.
|
Viruses
|
2015
|
0.80
|
|
25
|
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.
|
J Exp Clin Cancer Res
|
2014
|
0.80
|
|
26
|
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin.
|
BMC Cancer
|
2014
|
0.78
|
|
27
|
Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy.
|
Ther Deliv
|
2015
|
0.78
|
|
28
|
Assessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"?
|
Mol Ther Oncolytics
|
2015
|
0.77
|
|
29
|
Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.
|
Haematologica
|
2014
|
0.76
|
|
30
|
Advances in the design and development of oncolytic measles viruses.
|
Oncolytic Virother
|
2015
|
0.75
|
|
31
|
Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.
|
Neurosurgery
|
2014
|
0.75
|
|
32
|
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.
|
Hum Vaccin Immunother
|
2015
|
0.75
|
|
33
|
MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.
|
Mol Oncol
|
2016
|
0.75
|